New York, NY – September 17, 2025 – The global CBD pet market, fueled by rising awareness of natural supplements and therapeutic benefits of cannabis for pets, is projected to skyrocket from USD 944.69 million in 2025 to USD 4,456.97 million by 2033, achieving a robust compound annual growth rate (CAGR) of 21.4%. This surge follows a strong 2024 valuation of USD 778.16 million, highlighting the pet industry's shift toward organic and wellness-focused products like CBD oils, treats, and chews.

According to the latest market research from Straits Research, the CBD pet market growth is propelled by evolving consumer preferences for holistic pet health solutions. With pet humanization trends on the rise—treating pets as family members—owners are increasingly turning to CBD-based products to address issues like joint pain, anxiety, stress, epilepsy, and general wellness. The 2018 Farm Bill, which legalized hemp-derived CBD by distinguishing it from marijuana, has been a game-changer, unlocking vast potential for innovation in the pet CBD space.

Get Free Report Sample PDF : https://straitsresearch.com/report/cbd-pet-market/request-sample 

Key Drivers Fueling CBD Pet Market Expansion

The CBD pet market is experiencing accelerated growth due to several pivotal factors:

• Shifting Consumer Preferences Toward Organic Pet Products: A 2017 American Pet Products Association (APPA) survey revealed that 39% of dog owners and 34% of cat owners are open to CBD supplements for their pets, with current usage at 11% for dogs and 8% for cats. This trend mirrors the broader demand for natural nutrition, boosting sales of CBD-infused treats, chews, and oils.

• Boom in Companies Entering the Pet CBD Arena: Leading brands like cbdMD, Charlotte's Web, and Medterra are expanding from human to pet CBD products, intensifying competition. Established players such as Pet Releaf, Treatibles, and Canna-Pet face challenges from newcomers, while giants like Mars and Nestlé eye entry with their superior supply chains and brand power. Emerging U.S. brands including HempMy Pet, Fomo Bones, Honest Paws, and Joy Organics are capitalizing on the USD 95.7 billion spent on U.S. pets in 2019 alone.

• Regulatory Tailwinds and Scientific Backing: While the FDA issued warnings in 2019 to 13 companies for unapproved CBD pet claims, Europe's full legalization of CBD has made it the dominant region by market share. Ongoing research into CBD's benefits for pets, coupled with transparent policies allowing veterinarians to recommend products, is building trust and driving adoption.

"Pet owners are prioritizing evidence-based wellness for their furry companions, and CBD's therapeutic potential is at the forefront," said [Analyst Name], Senior Market Researcher at Straits Research. "As legalization spreads and more studies validate benefits for joint pain relief and anxiety reduction in pets, the market will see unprecedented growth through 2033."

Regional Insights: North America and Europe Lead the Charge

North America commands over half the global CBD pet market share, with the U.S. leading due to high pet care spending and a surge in specialized brands. In 2019, Americans spent nearly USD 96 billion on pets, paving the way for acquisitions by majors like Nestlé Purina and Mars Inc.

Europe, holding the largest share in 2019, benefits from widespread CBD legalization and a booming pet population—85 million households own pets, with cats (102.7 million across Europe and Russia) and dogs (84.9 million) dominating. The European Pet Food Industry (FEDIAF) reports USD 21 billion in annual pet spending, with pet food sales reaching USD 24.44 billion and a 2.6% growth rate.

Other regions like Asia-Pacific, Latin America, and the Middle East & Africa are emerging, supported by increasing pet ownership and e-commerce penetration.

Get Free Report Sample PDF : https://straitsresearch.com/report/cbd-pet-market/request-sample 

Segmental Breakdown: Food-Grade CBD Products Dominate

The food-grade segment, including treats and chews, captured the highest share in 2019, driven by rising pet nutrition expenditures. Brands like Better Choice's Bona Vida offer targeted formulations for heart support, muscle & joint health, and skin care. APPA data shows average annual costs for dog owners at USD 259 for food and USD 58 for vitamins, underscoring the demand for premium CBD integrations.

By application, joint pain and anxiety/stress relief lead, while end-users span veterinary pharmacies, pet specialty stores, e-commerce, and CBD stores. Key players include Canna-Pet, Charlotte's Web, HolistaPet, Honest Paws, Joy Organics, Pet Releaf, and Petco.

Recent developments highlight momentum: In May 2020, Mary's Tails launched hemp CBD products in select PetSmart stores across U.S. states like Colorado and Oregon. Meanwhile, Choom secured exclusive Canadian distribution for Better Choice's Bona Vida CBD pet line.

About Straits Research

Straits Research is a leading market intelligence firm providing actionable insights and data-driven strategies to businesses worldwide. Our comprehensive reports on emerging sectors like the CBD pet market equip stakeholders with the foresight needed to navigate regulatory landscapes and capitalize on growth opportunities.